4 Matching Annotations
  1. Aug 2020
  2. Nov 2017
    1. Via email, the primary investigator of COURAGE, Dr William Boden (Boston University, MA), highlighted that investigators found no subset of patients that did better with PCI vs OMT. Not those with multivessel disease and EF<50%, not those with LAD disease, and not those with nuclear studies showing moderate-severe ischemia.[7–9]
    2. espected investigators from Imperial College London have shaken the core of cardiology. The stakes could not be bigger. Millions of people have received stents for stable coronary artery disease (CAD) at a cost of billions of dollars.
    3. Coronary Stents Humbled Yet Again in Stable CAD